Maternal and neonatal cytokine profiles in a twin cohort: evidence from an exploratory pilot study of perinatal immune dysregulation in autism

Abstract Background Autism spectrum disorder (ASD) has been linked to immune dysregulation during early development, yet few studies jointly examine maternal pregnancy and cord blood (CB) cytokines in relation to later diagnosis. Methods In a nested case–control design within the Peri/Postnatal Epigenetic Twins Study, we measured 19 cytokines in maternal pregnancy serum (~28 weeks) and CB at birth. Participants included autism cases ( n = 15), controls ( n = 72), mothers of autism cases ( n = 11), and control mothers ( n = 36). In this exploratory pilot study, CB cytokine–autism associations were analyzed using generalized estimating equations, maternal cytokines using logistic regression, and maternal–cord associations using linear mixed-effects models. False discovery rate (FDR) correction was applied. Results Elevated CB IL-1α ( p = 0.038), IL-5 ( p = 0.036), IL-12p40 ( p = 0.016), and GM-CSF ( p = 0.016) were significantly associated with autism following FDR correction. Combined, these cytokines demonstrated apparent discriminatory ability (AUC = 0.93; 95% CI 0.85–1.0) within the study sample. No maternal pregnancy cytokines were independently associated with autism. Maternal–cord analyses revealed cytokine‑specific coupling differences, particularly for IL-1α and IL-5 (both p = 0.008, FDR corrected). Conclusion Selective CB cytokine differences at birth are associated with later ASD diagnosis, supporting a role for perinatal immune signaling in neurodevelopment. Replication in larger cohorts is recommended for further validation. Impact In twins, cord blood cytokine signatures at birth are associated with autism diagnosis at 6 years. Elevated IL‑1α, IL‑5, IL‑12p40 and GM‑CSF characterize autism cases and show strong individual‑level discriminative performance. Combined cord blood cytokines can discriminate autism from controls, highlighting potential biomarker utility. Different maternal-cord cytokine coupling suggests disrupted late‑gestation immune signaling relevant to neurodevelopment.

Authors

Institutions

Publication Details

Journal
Pediatric Research
Published
2026-07-22
DOI
https://doi.org/10.1038/s41390-026-05308-6
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Maternal and neonatal cytokine profiles in a twin cohort: evidence from an exploratory pilot study of perinatal immune dysregulation in autism

G. Stephenson, Craig Wright, Mohammadreza Mohebbi, Craig JM et al.
Pediatric Research
Autism Spectrum Disorder Research
article

Maternal and neonatal cytokine profiles in a twin cohort: evidence from an exploratory pilot study of perinatal immune dysregulation in autism

G. Stephenson, Craig Wright, Mohammadreza Mohebbi, Craig JM, Richard J. Williams, Md Ashik Imran, Richard Saffery
article en

Abstract

Abstract Background Autism spectrum disorder (ASD) has been linked to immune dysregulation during early development, yet few studies jointly examine maternal pregnancy and cord blood (CB) cytokines in relation to later diagnosis. Methods In a nested case–control design within the Peri/Postnatal Epigenetic Twins Study, we measured 19 cytokines in maternal pregnancy serum (~28 weeks) and CB at birth. Participants included autism cases ( n = 15), controls ( n = 72), mothers of autism cases ( n = 11), and control mothers ( n = 36). In this exploratory pilot study, CB cytokine–autism associations were analyzed using generalized estimating equations, maternal cytokines using logistic regression, and maternal–cord associations using linear mixed-effects models. False discovery rate (FDR) correction was applied. Results Elevated CB IL-1α ( p = 0.038), IL-5 ( p = 0.036), IL-12p40 ( p = 0.016), and GM-CSF ( p = 0.016) were significantly associated with autism following FDR correction. Combined, these cytokines demonstrated apparent discriminatory ability (AUC = 0.93; 95% CI 0.85–1.0) within the study sample. No maternal pregnancy cytokines were independently associated with autism. Maternal–cord analyses revealed cytokine‑specific coupling differences, particularly for IL-1α and IL-5 (both p = 0.008, FDR corrected). Conclusion Selective CB cytokine differences at birth are associated with later ASD diagnosis, supporting a role for perinatal immune signaling in neurodevelopment. Replication in larger cohorts is recommended for further validation. Impact In twins, cord blood cytokine signatures at birth are associated with autism diagnosis at 6 years. Elevated IL‑1α, IL‑5, IL‑12p40 and GM‑CSF characterize autism cases and show strong individual‑level discriminative performance. Combined cord blood cytokines can discriminate autism from controls, highlighting potential biomarker utility. Different maternal-cord cytokine coupling suggests disrupted late‑gestation immune signaling relevant to neurodevelopment.

Pediatric Research
Deakin University (AU), The University of Melbourne (AU), Murdoch Children's Research Institute (AU)
Reduced inequalities
Openalex Percentile: Top 7%
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.